Many patients who are interested in Pemgarda have been unable to get it because of lack of awareness among doctors, a limited number of infusion centers administering it, eligibility criteria, and insurance denials.
Frustrations, denials, long drives: Immunocompromised people can’t access a lifesaving Covid-19 drug - The Sick Times
A new drug approved months ago to help prevent Covid-19 infections could be a game changer for high-risk people — if they can get their hands on it. But many say they have struggled to access the medication.